Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE1B | Q01064 | 8/20 | 0.45 |
| ▸ | PDE1A | P54750 | 7/20 | 0.45 |
| ▸ | PDE1C | Q14123 | 7/20 | 0.45 |
| ▸ | PDE2A | O00408 | 4/20 | 0.45 |
| ▸ | SLC16A1 | P53985 | 8/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7004668 | 0.85 | SLC16A1 (0.46) | PDE1BPDE1APDE1CPDE2ASLC16A1 | |
| SCHEMBL7005664 | 0.83 | PDE1A (0.43) | PDE1BPDE1APDE1CPDE2ASLC16A1 | |
| SCHEMBL7005435 | 0.83 | PDE1B (0.57) | PDE1BPDE1APDE1CPDE2ASLC16A1 | |
| SCHEMBL5864831 | 0.80 | SLC16A1 (0.58) | PDE1BPDE1APDE1CPDE2ASLC16A1 | |
| SCHEMBL5864669 | 0.80 | PDE1B (0.47) | PDE1BPDE1APDE1CPDE2ASLC16A1 | |
| SCHEMBL7007438 | 0.79 | SLC16A1 (0.44) | PDE1BPDE1APDE1CPDE2ASLC16A1 | |
| SCHEMBL5864675 | 0.79 | LMNA (0.44) | PDE1BPDE1APDE1CPDE2ASLC16A1 | |
| SCHEMBL6808474 | 0.79 | MAPK1 (0.49) | PDE1BPDE1APDE1CPDE2ASLC16A1 | |
| SCHEMBL7007060 | 0.79 | SLC16A1 (0.43) | PDE1BPDE1APDE1CPDE2ASLC16A1 | |
| SCHEMBL7014557 | 0.78 | PDE1A (0.42) | PDE1BPDE1APDE1CPDE2ASLC16A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1107973-B1 | NOVEL THIENO[2,3-d]PYRIMIDINEDIONES, PROCESS FOR THEIR PREPARATION AND USE THEREOF IN THERAPY | ASTRAZENECA AB (SE) | 2003-11-05 | — | — | EP | claimed |
| US-6300334-B1 | DRUGS FOR TREATMENT OF RESPIRATORY SYSTEM DISORDERS | ASTRAZENECA AB (SE) | 2001-10-09 | — | — | US | claimed |
| EP-1107973-A1 | NOVEL COMPOUNDS | AstraZeneca AB (SE) | 2001-06-20 | — | — | EP | claimed |
| WO-2000012514-A1 | NOVEL COMPOUNDS | ASTRAZENECA AB (SE) | 2000-03-09 | — | — | WO | claimed |
| EP-1107973-B1 | NOVEL THIENO[2,3-d]PYRIMIDINEDIONES, PROCESS FOR THEIR PREPARATION AND USE THEREOF IN THERAPY | ASTRAZENECA AB (SE) | 2003-11-05 | — | — | EP | disclosed |
| US-6300334-B1 | DRUGS FOR TREATMENT OF RESPIRATORY SYSTEM DISORDERS | ASTRAZENECA AB (SE) | 2001-10-09 | — | — | US | disclosed |
| EP-1107973-A1 | NOVEL COMPOUNDS | AstraZeneca AB (SE) | 2001-06-20 | — | — | EP | disclosed |
| WO-2000012514-A1 | NOVEL COMPOUNDS | ASTRAZENECA AB (SE) | 2000-03-09 | — | — | WO | disclosed |